APO Research

APO RESEARCH · REPORT

Taurine Eye Drop

Selected research

Industry Growth & Trends

Global Taurine Eye Drop Industry Growth and Trends Forecast to 2032

Market perspective

The global Taurine Eye Drop market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Taurine Eye Drop is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Taurine Eye Drop is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Taurine Eye Drop is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Taurine Eye Drop include Changchun Changqing Pharmaceutical Group Co., Ltd., Changchun Dirui Pharmaceutical Co., Ltd., Wuhan Wujing Pharmaceutical Co., Ltd., Shijiazhuang Grey Pharmaceutical Co., Ltd., Shenyang Xingqi Eye Medicine Co., Ltd., Shanghai Xiaofang Pharmaceutical Co., Ltd., Shandong Chenxin Fodu Pharmaceutical Co., Ltd., Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. and Ningxia Kangya Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Taurine Eye Drop market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Taurine Eye Drop market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Taurine Eye Drop market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Taurine Eye Drop.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Taurine Eye Drop market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Taurine Eye Drop Market by Company

Changchun Changqing Pharmaceutical Group Co., Ltd.

Changchun Dirui Pharmaceutical Co., Ltd.

Wuhan Wujing Pharmaceutical Co., Ltd.

Shijiazhuang Grey Pharmaceutical Co., Ltd.

Shenyang Xingqi Eye Medicine Co., Ltd.

Shanghai Xiaofang Pharmaceutical Co., Ltd.

Shandong Chenxin Fodu Pharmaceutical Co., Ltd.

Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.

Ningxia Kangya Pharmaceutical Co., Ltd.

Mentholatum

Liaoning Yifan Pharmaceutical Co., Ltd.

Liaoning Qianliming Pharmaceutical (Group) Co., Ltd.

Roxy Pharmaceutical Shijiazhuang Co., Ltd.

Jiangxi Zhenshiming Pharmaceutical Co., Ltd.

Jiangsu Yuanheng Pharmaceutical Co., Ltd.

Jiangsu Jibei Pharmaceutical Co., Ltd.

Hubei Zhongjia Pharmaceutical Co., Ltd.

Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd.

Heilongjiang Tianlong Pharmaceutical Co., Ltd.

Hangzhou Guoguang Pharmaceutical Co., Ltd.

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Guangdong Matsushita Pharmaceutical Co., Ltd.

Guangdong Nanguo Pharmaceutical Co., Ltd.

Guangdong Hengjian Pharmaceutical Co., Ltd.

Taurine Eye Drop Segment by Type

5ml

10ml

Others

Taurine Eye Drop Segment by Application

Online Sales

Offline Sales

Taurine Eye Drop Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taurine Eye Drop market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Taurine Eye Drop and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taurine Eye Drop.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Taurine Eye Drop manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Taurine Eye Drop in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5ml Table 2. Major Company of 10ml Table 3. Major Company of Others Table 4. Global Taurine Eye Drop Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Taurine Eye Drop Sales by Type (2021-2026) & (K Units) Table 6. Global Taurine Eye Drop Sales Market Share in Volume by Type (2021-2026) Table 7. Global Taurine Eye Drop Sales by Type (2021-2026) & (US$ Million) Table 8. Global Taurine Eye Drop Sales Market Share in Value by Type (2021-2026) Table 9. Global Taurine Eye Drop Price by Type (2021-2026) & (US$/Unit) Table 10. Global Taurine Eye Drop Sales by Type (2027-2032) & (K Units) Table 11. Global Taurine Eye Drop Sales Market Share in Volume by Type (2027-2032) Table 12. Global Taurine Eye Drop Sales by Type (2027-2032) & (US$ Million) Table 13. Global Taurine Eye Drop Sales Market Share in Value by Type (2027-2032) Table 14. Global Taurine Eye Drop Price by Type (2027-2032) & (US$/Unit) Table 15. North America Taurine Eye Drop Sales by Type (2021-2026) & (K Units) Table 16. North America Taurine Eye Drop Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Taurine Eye Drop Sales by Type (2021-2026) & (K Units) Table 18. Europe Taurine Eye Drop Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Taurine Eye Drop Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Taurine Eye Drop Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Taurine Eye Drop Sales by Type (2021-2026) & (K Units) Table 22. Latin America Taurine Eye Drop Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Taurine Eye Drop Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Taurine Eye Drop Sales by Type (2021-2026) & (US$ Million) Table 25. Taurine Eye Drop Industry Trends Table 26. Taurine Eye Drop Industry Drivers Table 27. Taurine Eye Drop Industry Opportunities and Challenges Table 28. Taurine Eye Drop Industry Restraints Table 29. Global Taurine Eye Drop Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Taurine Eye Drop Revenue Market Share by Company (2021-2026) Table 31. Global Taurine Eye Drop Sales by Company (2021-2026) & (K Units) Table 32. Global Taurine Eye Drop Sales Share by Company (2021-2026) Table 33. Global Taurine Eye Drop Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Taurine Eye Drop Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Taurine Eye Drop Major Company Production Sites and Headquarters Table 36. Global Taurine Eye Drop Company, Product Type & Application Table 37. Global Taurine Eye Drop Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Taurine Eye Drop by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Taurine Eye Drop Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Taurine Eye Drop Sales by Region (2021-2026) & (K Units) Table 42. Global Taurine Eye Drop Sales Market Share in Volume by Region (2021-2026) Table 43. Global Taurine Eye Drop Sales by Region (2021-2026) & (US$ Million) Table 44. Global Taurine Eye Drop Sales Market Share in Value by Region (2021-2026) Table 45. Global Taurine Eye Drop Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Taurine Eye Drop Sales by Region (2027-2032) & (K Units) Table 47. Global Taurine Eye Drop Sales Market Share in Volume by Region (2027-2032) Table 48. Global Taurine Eye Drop Sales by Region (2027-2032) & (US$ Million) Table 49. Global Taurine Eye Drop Sales Market Share in Value by Region (2027-2032) Table 50. Global Taurine Eye Drop Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Taurine Eye Drop Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Taurine Eye Drop Sales by Application (2021-2026) & (K Units) Table 53. Global Taurine Eye Drop Sales Market Share in Volume by Application (2021-2026) Table 54. Global Taurine Eye Drop Sales by Application (2021-2026) & (US$ Million) Table 55. Global Taurine Eye Drop Sales Market Share in Value by Application (2021-2026) Table 56. Global Taurine Eye Drop Price by Application (2021-2026) & (US$/Unit) Table 57. Global Taurine Eye Drop Sales by Application (2027-2032) & (K Units) Table 58. Global Taurine Eye Drop Sales Market Share in Volume by Application (2027-2032) Table 59. Global Taurine Eye Drop Sales by Application (2027-2032) & (US$ Million) Table 60. Global Taurine Eye Drop Sales Market Share in Value by Application (2027-2032) Table 61. Global Taurine Eye Drop Price by Application (2027-2032) & (US$/Unit) Table 62. North America Taurine Eye Drop Sales by Application (2021-2026) & (K Units) Table 63. North America Taurine Eye Drop Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Taurine Eye Drop Sales by Application (2021-2026) & (K Units) Table 65. Europe Taurine Eye Drop Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Taurine Eye Drop Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Taurine Eye Drop Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Taurine Eye Drop Sales by Application (2021-2026) & (K Units) Table 69. Latin America Taurine Eye Drop Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Taurine Eye Drop Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Taurine Eye Drop Sales by Application (2021-2026) & (US$ Million) Table 72. Changchun Changqing Pharmaceutical Group Co., Ltd. Company Information Table 73. Changchun Changqing Pharmaceutical Group Co., Ltd. Business Overview Table 74. Changchun Changqing Pharmaceutical Group Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Changchun Changqing Pharmaceutical Group Co., Ltd. Taurine Eye Drop Product Portfolio Table 76. Changchun Changqing Pharmaceutical Group Co., Ltd. Recent Development Table 77. Changchun Dirui Pharmaceutical Co., Ltd. Company Information Table 78. Changchun Dirui Pharmaceutical Co., Ltd. Business Overview Table 79. Changchun Dirui Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Changchun Dirui Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 81. Changchun Dirui Pharmaceutical Co., Ltd. Recent Development Table 82. Wuhan Wujing Pharmaceutical Co., Ltd. Company Information Table 83. Wuhan Wujing Pharmaceutical Co., Ltd. Business Overview Table 84. Wuhan Wujing Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Wuhan Wujing Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 86. Wuhan Wujing Pharmaceutical Co., Ltd. Recent Development Table 87. Shijiazhuang Grey Pharmaceutical Co., Ltd. Company Information Table 88. Shijiazhuang Grey Pharmaceutical Co., Ltd. Business Overview Table 89. Shijiazhuang Grey Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Shijiazhuang Grey Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 91. Shijiazhuang Grey Pharmaceutical Co., Ltd. Recent Development Table 92. Shenyang Xingqi Eye Medicine Co., Ltd. Company Information Table 93. Shenyang Xingqi Eye Medicine Co., Ltd. Business Overview Table 94. Shenyang Xingqi Eye Medicine Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Shenyang Xingqi Eye Medicine Co., Ltd. Taurine Eye Drop Product Portfolio Table 96. Shenyang Xingqi Eye Medicine Co., Ltd. Recent Development Table 97. Shanghai Xiaofang Pharmaceutical Co., Ltd. Company Information Table 98. Shanghai Xiaofang Pharmaceutical Co., Ltd. Business Overview Table 99. Shanghai Xiaofang Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Shanghai Xiaofang Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 101. Shanghai Xiaofang Pharmaceutical Co., Ltd. Recent Development Table 102. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information Table 103. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview Table 104. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 106. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Development Table 107. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information Table 108. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview Table 109. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 111. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Development Table 112. Ningxia Kangya Pharmaceutical Co., Ltd. Company Information Table 113. Ningxia Kangya Pharmaceutical Co., Ltd. Business Overview Table 114. Ningxia Kangya Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Ningxia Kangya Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 116. Ningxia Kangya Pharmaceutical Co., Ltd. Recent Development Table 117. Mentholatum Company Information Table 118. Mentholatum Business Overview Table 119. Mentholatum Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Mentholatum Taurine Eye Drop Product Portfolio Table 121. Mentholatum Recent Development Table 122. Liaoning Yifan Pharmaceutical Co., Ltd. Company Information Table 123. Liaoning Yifan Pharmaceutical Co., Ltd. Business Overview Table 124. Liaoning Yifan Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Liaoning Yifan Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 126. Liaoning Yifan Pharmaceutical Co., Ltd. Recent Development Table 127. Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Company Information Table 128. Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Business Overview Table 129. Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Taurine Eye Drop Product Portfolio Table 131. Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Recent Development Table 132. Roxy Pharmaceutical Shijiazhuang Co., Ltd. Company Information Table 133. Roxy Pharmaceutical Shijiazhuang Co., Ltd. Business Overview Table 134. Roxy Pharmaceutical Shijiazhuang Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Roxy Pharmaceutical Shijiazhuang Co., Ltd. Taurine Eye Drop Product Portfolio Table 136. Roxy Pharmaceutical Shijiazhuang Co., Ltd. Recent Development Table 137. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Company Information Table 138. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Business Overview Table 139. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 141. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Recent Development Table 142. Jiangsu Yuanheng Pharmaceutical Co., Ltd. Company Information Table 143. Jiangsu Yuanheng Pharmaceutical Co., Ltd. Business Overview Table 144. Jiangsu Yuanheng Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Jiangsu Yuanheng Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 146. Jiangsu Yuanheng Pharmaceutical Co., Ltd. Recent Development Table 147. Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information Table 148. Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview Table 149. Jiangsu Jibei Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Jiangsu Jibei Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 151. Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Development Table 152. Hubei Zhongjia Pharmaceutical Co., Ltd. Company Information Table 153. Hubei Zhongjia Pharmaceutical Co., Ltd. Business Overview Table 154. Hubei Zhongjia Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Hubei Zhongjia Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 156. Hubei Zhongjia Pharmaceutical Co., Ltd. Recent Development Table 157. Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Company Information Table 158. Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Business Overview Table 159. Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 161. Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Recent Development Table 162. Heilongjiang Tianlong Pharmaceutical Co., Ltd. Company Information Table 163. Heilongjiang Tianlong Pharmaceutical Co., Ltd. Business Overview Table 164. Heilongjiang Tianlong Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Heilongjiang Tianlong Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 166. Heilongjiang Tianlong Pharmaceutical Co., Ltd. Recent Development Table 167. Hangzhou Guoguang Pharmaceutical Co., Ltd. Company Information Table 168. Hangzhou Guoguang Pharmaceutical Co., Ltd. Business Overview Table 169. Hangzhou Guoguang Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Hangzhou Guoguang Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 171. Hangzhou Guoguang Pharmaceutical Co., Ltd. Recent Development Table 172. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Company Information Table 173. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Business Overview Table 174. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 176. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Recent Development Table 177. Guangdong Matsushita Pharmaceutical Co., Ltd. Company Information Table 178. Guangdong Matsushita Pharmaceutical Co., Ltd. Business Overview Table 179. Guangdong Matsushita Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Guangdong Matsushita Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 181. Guangdong Matsushita Pharmaceutical Co., Ltd. Recent Development Table 182. Guangdong Nanguo Pharmaceutical Co., Ltd. Company Information Table 183. Guangdong Nanguo Pharmaceutical Co., Ltd. Business Overview Table 184. Guangdong Nanguo Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Guangdong Nanguo Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 186. Guangdong Nanguo Pharmaceutical Co., Ltd. Recent Development Table 187. Guangdong Hengjian Pharmaceutical Co., Ltd. Company Information Table 188. Guangdong Hengjian Pharmaceutical Co., Ltd. Business Overview Table 189. Guangdong Hengjian Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. Guangdong Hengjian Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 191. Guangdong Hengjian Pharmaceutical Co., Ltd. Recent Development Table 192. North America Taurine Eye Drop Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 193. North America Taurine Eye Drop Sales by Country (2021-2026) & (K Units) Table 194. North America Taurine Eye Drop Sales Market Share by Country (2021-2026) Table 195. North America Taurine Eye Drop Sales Forecast by Country (2027-2032) & (K Units) Table 196. North America Taurine Eye Drop Sales Market Share Forecast by Country (2027-2032) Table 197. North America Taurine Eye Drop Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. North America Taurine Eye Drop Market Size by Country (2021-2026) & (US$ Million) Table 199. North America Taurine Eye Drop Market Share by Country (2021-2026) Table 200. North America Taurine Eye Drop Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. North America Taurine Eye Drop Market Share Forecast by Country (2027-2032) Table 202. Europe Taurine Eye Drop Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 203. Europe Taurine Eye Drop Sales by Country (2021-2026) & (K Units) Table 204. Europe Taurine Eye Drop Sales Market Share by Country (2021-2026) Table 205. Europe Taurine Eye Drop Sales Forecast by Country (2027-2032) & (K Units) Table 206. Europe Taurine Eye Drop Sales Market Share Forecast by Country (2027-2032) Table 207. Europe Taurine Eye Drop Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Europe Taurine Eye Drop Market Size by Country (2021-2026) & (US$ Million) Table 209. Europe Taurine Eye Drop Market Share by Country (2021-2026) Table 210. Europe Taurine Eye Drop Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Europe Taurine Eye Drop Market Share Forecast by Country (2027-2032) Table 212. Asia-Pacific Taurine Eye Drop Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 213. Asia-Pacific Taurine Eye Drop Sales by Country (2021-2026) & (K Units) Table 214. Asia-Pacific Taurine Eye Drop Sales Market Share by Country (2021-2026) Table 215. Asia-Pacific Taurine Eye Drop Sales Forecast by Country (2027-2032) & (K Units) Table 216. Asia-Pacific Taurine Eye Drop Sales Market Share Forecast by Country (2027-2032) Table 217. Asia-Pacific Taurine Eye Drop Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 218. Asia-Pacific Taurine Eye Drop Market Size by Country (2021-2026) & (US$ Million) Table 219. Asia-Pacific Taurine Eye Drop Market Share by Country (2021-2026) Table 220. Asia-Pacific Taurine Eye Drop Market Size Forecast by Country (2027-2032) & (US$ Million) Table 221. Asia-Pacific Taurine Eye Drop Market Share Forecast by Country (2027-2032) Table 222. Latin America Taurine Eye Drop Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 223. Latin America Taurine Eye Drop Sales by Country (2021-2026) & (K Units) Table 224. Latin America Taurine Eye Drop Sales Market Share by Country (2021-2026) Table 225. Latin America Taurine Eye Drop Sales Forecast by Country (2027-2032) & (K Units) Table 226. Latin America Taurine Eye Drop Sales Market Share Forecast by Country (2027-2032) Table 227. Latin America Taurine Eye Drop Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 228. Latin America Taurine Eye Drop Market Size by Country (2021-2026) & (US$ Million) Table 229. Latin America Taurine Eye Drop Market Share by Country (2021-2026) Table 230. Latin America Taurine Eye Drop Market Size Forecast by Country (2027-2032) & (US$ Million) Table 231. Latin America Taurine Eye Drop Market Share Forecast by Country (2027-2032) Table 232. Middle East and Africa Taurine Eye Drop Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 233. Middle East and Africa Taurine Eye Drop Sales by Country (2021-2026) & (K Units) Table 234. Middle East and Africa Taurine Eye Drop Sales Market Share by Country (2021-2026) Table 235. Middle East and Africa Taurine Eye Drop Sales Forecast by Country (2027-2032) & (K Units) Table 236. Middle East and Africa Taurine Eye Drop Sales Market Share Forecast by Country (2027-2032) Table 237. Middle East and Africa Taurine Eye Drop Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 238. Middle East and Africa Taurine Eye Drop Market Size by Country (2021-2026) & (US$ Million) Table 239. Middle East and Africa Taurine Eye Drop Market Share by Country (2021-2026) Table 240. Middle East and Africa Taurine Eye Drop Market Size Forecast by Country (2027-2032) & (US$ Million) Table 241. Middle East and Africa Taurine Eye Drop Market Share Forecast by Country (2027-2032) Table 242. Key Raw Materials Table 243. Raw Materials Key Suppliers Table 244. Taurine Eye Drop Distributors List Table 245. Taurine Eye Drop Customers List Table 246. Research Programs/Design for This Report Table 247. Authors List of This Report Table 248. Secondary Sources Table 249. Primary Sources List of Figures Figure 1. Taurine Eye Drop Image Figure 2. Global Taurine Eye Drop Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Taurine Eye Drop Market Size (2021-2032) & (US$ Million) Figure 4. Global Taurine Eye Drop Sales (2021-2032) & (K Units) Figure 5. 5ml Image Figure 6. Global 5ml Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10ml Image Figure 8. Global 10ml Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Taurine Eye Drop Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Taurine Eye Drop Market Share by Type 2025 VS 2032 Figure 13. North America Taurine Eye Drop Sales Market Share in Volume by Type in 2025 Figure 14. North America Taurine Eye Drop Sales Market Share in Value by Type in 2025 Figure 15. Europe Taurine Eye Drop Sales Market Share in Volume by Type in 2025 Figure 16. Europe Taurine Eye Drop Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Taurine Eye Drop Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Taurine Eye Drop Sales Market Share in Value by Type in 2025 Figure 19. Latin America Taurine Eye Drop Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Taurine Eye Drop Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Taurine Eye Drop Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Taurine Eye Drop Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Taurine Eye Drop Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Online Sales Image Figure 26. Global Online Sales Sales YoY Growth (2021-2032) & (K Units) Figure 27. Offline Sales Image Figure 28. Global Offline Sales Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Taurine Eye Drop Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Taurine Eye Drop Market Share by Application 2025 VS 2032 Figure 31. North America Taurine Eye Drop Sales Market Share in Volume by Application in 2025 Figure 32. North America Taurine Eye Drop Sales Market Share in Value by Application in 2025 Figure 33. Europe Taurine Eye Drop Sales Market Share in Volume by Application in 2025 Figure 34. Europe Taurine Eye Drop Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Taurine Eye Drop Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Taurine Eye Drop Sales Market Share in Value by Application in 2025 Figure 37. Latin America Taurine Eye Drop Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Taurine Eye Drop Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Taurine Eye Drop Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Taurine Eye Drop Sales Market Share in Value by Application in 2025 Figure 41. North America Taurine Eye Drop Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Taurine Eye Drop Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Taurine Eye Drop Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Taurine Eye Drop Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Taurine Eye Drop Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Taurine Eye Drop Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Taurine Eye Drop Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Taurine Eye Drop Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Taurine Eye Drop Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Taurine Eye Drop Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Taurine Eye Drop Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Taurine Eye Drop Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Taurine Eye Drop Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Taurine Eye Drop Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Taurine Eye Drop Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Taurine Eye Drop Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Taurine Eye Drop Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Taurine Eye Drop Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Taurine Eye Drop Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Taurine Eye Drop Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Taurine Eye Drop Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Taurine Eye Drop Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 5ml
  • 10ml
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Changchun Changqing Pharmaceutical Group Co., Ltd.
  • Changchun Dirui Pharmaceutical Co., Ltd.
  • Wuhan Wujing Pharmaceutical Co., Ltd.
  • Shijiazhuang Grey Pharmaceutical Co., Ltd.
  • Shenyang Xingqi Eye Medicine Co., Ltd.
  • Shanghai Xiaofang Pharmaceutical Co., Ltd.
  • Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  • Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  • Ningxia Kangya Pharmaceutical Co., Ltd.
  • Mentholatum
  • Liaoning Yifan Pharmaceutical Co., Ltd.
  • Liaoning Qianliming Pharmaceutical (Group) Co., Ltd.
  • Roxy Pharmaceutical Shijiazhuang Co., Ltd.
  • Jiangxi Zhenshiming Pharmaceutical Co., Ltd.
  • Jiangsu Yuanheng Pharmaceutical Co., Ltd.
  • Jiangsu Jibei Pharmaceutical Co., Ltd.
  • Hubei Zhongjia Pharmaceutical Co., Ltd.
  • Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd.
  • Heilongjiang Tianlong Pharmaceutical Co., Ltd.
  • Hangzhou Guoguang Pharmaceutical Co., Ltd.
  • Guangdong Zhongsheng Pharmaceutical Co., Ltd.
  • Guangdong Matsushita Pharmaceutical Co., Ltd.
  • Guangdong Nanguo Pharmaceutical Co., Ltd.
  • Guangdong Hengjian Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Taurine Eye Drop Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Taurine Eye Drop Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Taurine Eye Drop Market by Type
  6. 1.3.1 5ml
  7. 1.3.2 10ml
  8. 1.3.3 Others
  9. 1.4 Global Taurine Eye Drop Market Size by Type
  10. 1.4.1 Global Taurine Eye Drop Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Taurine Eye Drop Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Taurine Eye Drop Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Taurine Eye Drop Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Taurine Eye Drop Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Taurine Eye Drop Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Taurine Eye Drop Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Taurine Eye Drop Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Taurine Eye Drop Industry Trends
  2. 2.2 Taurine Eye Drop Industry Drivers
  3. 2.3 Taurine Eye Drop Industry Opportunities and Challenges
  4. 2.4 Taurine Eye Drop Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Taurine Eye Drop Revenue (2021-2026)
  2. 3.2 Global Top Players by Taurine Eye Drop Sales (2021-2026)
  3. 3.3 Global Top Players by Taurine Eye Drop Price (2021-2026)
  4. 3.4 Global Taurine Eye Drop Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Taurine Eye Drop Major Company Production Sites & Headquarters
  6. 3.6 Global Taurine Eye Drop Company, Product Type & Application
  7. 3.7 Global Taurine Eye Drop Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Taurine Eye Drop Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Taurine Eye Drop Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Taurine Eye Drop Tier 1, Tier 2, and Tier 3
4 Taurine Eye Drop Regional Status and Outlook
  1. 4.1 Global Taurine Eye Drop Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Taurine Eye Drop Historic Market Size by Region
  3. 4.2.1 Global Taurine Eye Drop Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Taurine Eye Drop Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Taurine Eye Drop Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Taurine Eye Drop Forecasted Market Size by Region
  7. 4.3.1 Global Taurine Eye Drop Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Taurine Eye Drop Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Taurine Eye Drop Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Taurine Eye Drop by Application
  1. 5.1 Taurine Eye Drop Market by Application
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Taurine Eye Drop Market Size by Application
  5. 5.2.1 Global Taurine Eye Drop Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Taurine Eye Drop Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Taurine Eye Drop Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Taurine Eye Drop Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Taurine Eye Drop Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Taurine Eye Drop Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Taurine Eye Drop Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Taurine Eye Drop Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Changchun Changqing Pharmaceutical Group Co., Ltd.
  2. 6.1.1 Changchun Changqing Pharmaceutical Group Co., Ltd. Company Information
  3. 6.1.2 Changchun Changqing Pharmaceutical Group Co., Ltd. Business Overview
  4. 6.1.3 Changchun Changqing Pharmaceutical Group Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Changchun Changqing Pharmaceutical Group Co., Ltd. Taurine Eye Drop Product Portfolio
  6. 6.1.5 Changchun Changqing Pharmaceutical Group Co., Ltd. Recent Developments
  7. 6.2 Changchun Dirui Pharmaceutical Co., Ltd.
  8. 6.2.1 Changchun Dirui Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Changchun Dirui Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Changchun Dirui Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Changchun Dirui Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  12. 6.2.5 Changchun Dirui Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Wuhan Wujing Pharmaceutical Co., Ltd.
  14. 6.3.1 Wuhan Wujing Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Wuhan Wujing Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Wuhan Wujing Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Wuhan Wujing Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  18. 6.3.5 Wuhan Wujing Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Shijiazhuang Grey Pharmaceutical Co., Ltd.
  20. 6.4.1 Shijiazhuang Grey Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Shijiazhuang Grey Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Shijiazhuang Grey Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shijiazhuang Grey Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  24. 6.4.5 Shijiazhuang Grey Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Shenyang Xingqi Eye Medicine Co., Ltd.
  26. 6.5.1 Shenyang Xingqi Eye Medicine Co., Ltd. Company Information
  27. 6.5.2 Shenyang Xingqi Eye Medicine Co., Ltd. Business Overview
  28. 6.5.3 Shenyang Xingqi Eye Medicine Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shenyang Xingqi Eye Medicine Co., Ltd. Taurine Eye Drop Product Portfolio
  30. 6.5.5 Shenyang Xingqi Eye Medicine Co., Ltd. Recent Developments
  31. 6.6 Shanghai Xiaofang Pharmaceutical Co., Ltd.
  32. 6.6.1 Shanghai Xiaofang Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Shanghai Xiaofang Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Shanghai Xiaofang Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Xiaofang Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  36. 6.6.5 Shanghai Xiaofang Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  38. 6.7.1 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  42. 6.7.5 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  44. 6.8.1 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  48. 6.8.5 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Ningxia Kangya Pharmaceutical Co., Ltd.
  50. 6.9.1 Ningxia Kangya Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Ningxia Kangya Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Ningxia Kangya Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ningxia Kangya Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  54. 6.9.5 Ningxia Kangya Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Mentholatum
  56. 6.10.1 Mentholatum Company Information
  57. 6.10.2 Mentholatum Business Overview
  58. 6.10.3 Mentholatum Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mentholatum Taurine Eye Drop Product Portfolio
  60. 6.10.5 Mentholatum Recent Developments
  61. 6.11 Liaoning Yifan Pharmaceutical Co., Ltd.
  62. 6.11.1 Liaoning Yifan Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Liaoning Yifan Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Liaoning Yifan Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Liaoning Yifan Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  66. 6.11.5 Liaoning Yifan Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd.
  68. 6.12.1 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Company Information
  69. 6.12.2 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Business Overview
  70. 6.12.3 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Taurine Eye Drop Product Portfolio
  72. 6.12.5 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Recent Developments
  73. 6.13 Roxy Pharmaceutical Shijiazhuang Co., Ltd.
  74. 6.13.1 Roxy Pharmaceutical Shijiazhuang Co., Ltd. Company Information
  75. 6.13.2 Roxy Pharmaceutical Shijiazhuang Co., Ltd. Business Overview
  76. 6.13.3 Roxy Pharmaceutical Shijiazhuang Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Roxy Pharmaceutical Shijiazhuang Co., Ltd. Taurine Eye Drop Product Portfolio
  78. 6.13.5 Roxy Pharmaceutical Shijiazhuang Co., Ltd. Recent Developments
  79. 6.14 Jiangxi Zhenshiming Pharmaceutical Co., Ltd.
  80. 6.14.1 Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  84. 6.14.5 Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Jiangsu Yuanheng Pharmaceutical Co., Ltd.
  86. 6.15.1 Jiangsu Yuanheng Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Jiangsu Yuanheng Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Jiangsu Yuanheng Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Jiangsu Yuanheng Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  90. 6.15.5 Jiangsu Yuanheng Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Jiangsu Jibei Pharmaceutical Co., Ltd.
  92. 6.16.1 Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Jiangsu Jibei Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Jiangsu Jibei Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  96. 6.16.5 Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Hubei Zhongjia Pharmaceutical Co., Ltd.
  98. 6.17.1 Hubei Zhongjia Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Hubei Zhongjia Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Hubei Zhongjia Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Hubei Zhongjia Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  102. 6.17.5 Hubei Zhongjia Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd.
  104. 6.18.1 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  108. 6.18.5 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Recent Developments
  109. 6.19 Heilongjiang Tianlong Pharmaceutical Co., Ltd.
  110. 6.19.1 Heilongjiang Tianlong Pharmaceutical Co., Ltd. Company Information
  111. 6.19.2 Heilongjiang Tianlong Pharmaceutical Co., Ltd. Business Overview
  112. 6.19.3 Heilongjiang Tianlong Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Heilongjiang Tianlong Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  114. 6.19.5 Heilongjiang Tianlong Pharmaceutical Co., Ltd. Recent Developments
  115. 6.20 Hangzhou Guoguang Pharmaceutical Co., Ltd.
  116. 6.20.1 Hangzhou Guoguang Pharmaceutical Co., Ltd. Company Information
  117. 6.20.2 Hangzhou Guoguang Pharmaceutical Co., Ltd. Business Overview
  118. 6.20.3 Hangzhou Guoguang Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Hangzhou Guoguang Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  120. 6.20.5 Hangzhou Guoguang Pharmaceutical Co., Ltd. Recent Developments
  121. 6.21 Guangdong Zhongsheng Pharmaceutical Co., Ltd.
  122. 6.21.1 Guangdong Zhongsheng Pharmaceutical Co., Ltd. Company Information
  123. 6.21.2 Guangdong Zhongsheng Pharmaceutical Co., Ltd. Business Overview
  124. 6.21.3 Guangdong Zhongsheng Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Guangdong Zhongsheng Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  126. 6.21.5 Guangdong Zhongsheng Pharmaceutical Co., Ltd. Recent Developments
  127. 6.22 Guangdong Matsushita Pharmaceutical Co., Ltd.
  128. 6.22.1 Guangdong Matsushita Pharmaceutical Co., Ltd. Company Information
  129. 6.22.2 Guangdong Matsushita Pharmaceutical Co., Ltd. Business Overview
  130. 6.22.3 Guangdong Matsushita Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Guangdong Matsushita Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  132. 6.22.5 Guangdong Matsushita Pharmaceutical Co., Ltd. Recent Developments
  133. 6.23 Guangdong Nanguo Pharmaceutical Co., Ltd.
  134. 6.23.1 Guangdong Nanguo Pharmaceutical Co., Ltd. Company Information
  135. 6.23.2 Guangdong Nanguo Pharmaceutical Co., Ltd. Business Overview
  136. 6.23.3 Guangdong Nanguo Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Guangdong Nanguo Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  138. 6.23.5 Guangdong Nanguo Pharmaceutical Co., Ltd. Recent Developments
  139. 6.24 Guangdong Hengjian Pharmaceutical Co., Ltd.
  140. 6.24.1 Guangdong Hengjian Pharmaceutical Co., Ltd. Company Information
  141. 6.24.2 Guangdong Hengjian Pharmaceutical Co., Ltd. Business Overview
  142. 6.24.3 Guangdong Hengjian Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Guangdong Hengjian Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  144. 6.24.5 Guangdong Hengjian Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Taurine Eye Drop Sales by Country
  2. 7.1.1 North America Taurine Eye Drop Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Taurine Eye Drop Sales by Country (2021-2026)
  4. 7.1.3 North America Taurine Eye Drop Sales Forecast by Country (2027-2032)
  5. 7.2 North America Taurine Eye Drop Market Size by Country
  6. 7.2.1 North America Taurine Eye Drop Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Taurine Eye Drop Market Size by Country (2021-2026)
  8. 7.2.3 North America Taurine Eye Drop Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Taurine Eye Drop Sales by Country
  2. 8.1.1 Europe Taurine Eye Drop Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Taurine Eye Drop Sales by Country (2021-2026)
  4. 8.1.3 Europe Taurine Eye Drop Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Taurine Eye Drop Market Size by Country
  6. 8.2.1 Europe Taurine Eye Drop Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Taurine Eye Drop Market Size by Country (2021-2026)
  8. 8.2.3 Europe Taurine Eye Drop Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Taurine Eye Drop Sales by Country
  2. 9.1.1 Asia-Pacific Taurine Eye Drop Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Taurine Eye Drop Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Taurine Eye Drop Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Taurine Eye Drop Market Size by Country
  6. 9.2.1 Asia-Pacific Taurine Eye Drop Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Taurine Eye Drop Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Taurine Eye Drop Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Taurine Eye Drop Sales by Country
  2. 10.1.1 South America Taurine Eye Drop Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Taurine Eye Drop Sales by Country (2021-2026)
  4. 10.1.3 South America Taurine Eye Drop Sales Forecast by Country (2027-2032)
  5. 10.2 South America Taurine Eye Drop Market Size by Country
  6. 10.2.1 South America Taurine Eye Drop Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Taurine Eye Drop Market Size by Country (2021-2026)
  8. 10.2.3 South America Taurine Eye Drop Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Taurine Eye Drop Sales by Country
  2. 11.1.1 Middle East and Africa Taurine Eye Drop Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Taurine Eye Drop Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Taurine Eye Drop Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Taurine Eye Drop Market Size by Country
  6. 11.2.1 Middle East and Africa Taurine Eye Drop Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Taurine Eye Drop Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Taurine Eye Drop Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Taurine Eye Drop Value Chain Analysis
  2. 12.1.1 Taurine Eye Drop Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Taurine Eye Drop Production Mode & Process
  7. 12.2 Taurine Eye Drop Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Taurine Eye Drop Distributors
  10. 12.2.3 Taurine Eye Drop Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research